Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

Diane M. Harper(Dartmouth College), Eduardo L. Franco(McGill University), Cosette M. Wheeler(University of New Mexico), Daron G. Ferris(Augusta University), David Jenkins(GlaxoSmithKline (Belgium)), Anne Schuind(GlaxoSmithKline (United States)), Toufik Zahaf(GlaxoSmithKline (Belgium)), Bruce L. Innis(GlaxoSmithKline (United States)), Paulo Naud(Hospital de Clínicas de Porto Alegre), Newton Sérgio de Carvalho(Universidade Federal do Paraná), Cecília Roteli-Martins(Hospital São Paulo), Júlio César Teixeira(Universidade Estadual de Campinas (UNICAMP)), Mark M. Blatter(University Physicians), Abner Korn(University of California, San Francisco), Wim Quint(DDL Diagnostic Laboratory), Gary Dubin(GlaxoSmithKline (United States))
The Lancet
November 1, 2004
Cited by 1,643

Abstract


Related Papers

No related papers found

Powered by citation graph analysis